177 related articles for article (PubMed ID: 31343285)
1. Cardiac and peripheral vasomotor autonomic functions in hereditary transthyretin amyloidosis with non-Val30Met mutation.
Koike H; Nakamura T; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Katsuno M; Sobue G
Amyloid; 2019; 26(sup1):13-14. PubMed ID: 31343285
[No Abstract] [Full Text] [Related]
2. Cardiovascular autonomic functions in late-onset hereditary transthyretin amyloidosis with Val30Met mutation.
Nakamura T; Koike H; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Katsuno M; Sobue G
Amyloid; 2019; 26(sup1):6. PubMed ID: 31343341
[No Abstract] [Full Text] [Related]
3. Cardiac and peripheral vasomotor autonomic functions in late-onset transthyretin Val30Met familial amyloid polyneuropathy.
Koike H; Nakamura T; Hashizume A; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Katsuno M; Sobue G
J Neurol; 2017 Nov; 264(11):2293-2302. PubMed ID: 28983659
[TBL] [Abstract][Full Text] [Related]
4. Widespread Cardiac and Vasomotor Autonomic Dysfunction in Non-Val30Met Hereditary Transthyretin Amyloidosis.
Koike H; Nakamura T; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Katsuno M; Sobue G
Intern Med; 2018 Dec; 57(23):3365-3370. PubMed ID: 29984770
[TBL] [Abstract][Full Text] [Related]
5. Cardiac involvement after liver transplantation in patients with Val30Met transthyretin amyloidosis from Majorca focus.
Ripoll-Vera T; Alvarez J; Buades J; Cisneros E; Gomez Y; Melia C; Ferrer A; Losada I; Gonzalez J; Uson M; Figuerola A
Amyloid; 2019; 26(sup1):18-19. PubMed ID: 31343328
[No Abstract] [Full Text] [Related]
6. Cardiac involvement in a large cohort of patients with Val30Met transthyretin amyloidosis from Majorca focus.
Ripoll-Vera T; Alvarez J; Buades J; Cisneros E; Gomez Y; Melia C; Ferrer A; Losada I; Gonzalez J; Uson M; Figuerola A
Amyloid; 2019; 26(sup1):15-16. PubMed ID: 31343338
[No Abstract] [Full Text] [Related]
7. Evolution of amyloid fibrils in hereditary transthyretin amyloidosis: an ultrastructural study.
Koike H; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Katsuno M; Sobue G
Amyloid; 2019; 26(sup1):26. PubMed ID: 31343346
[No Abstract] [Full Text] [Related]
8. Clinical manifestations in hereditary amyloidosis with the variant Glu54Gln transthyretin.
Jercan A; Badelita S; Draghici M; Stoica E; Iacob S; Coriu D
Amyloid; 2019; 26(sup1):31-32. PubMed ID: 31343281
[No Abstract] [Full Text] [Related]
9. A case of familial amyloid polyneuropathy homozygous for the transthyretin Val30Met gene with motor-dominant sensorimotor polyneuropathy and unusual sural nerve pathological findings.
Yoshioka A; Yamaya Y; Saiki S; Hirose G; Shimazaki K; Nakamura M; Ando Y
Arch Neurol; 2001 Nov; 58(11):1914-8. PubMed ID: 11709003
[TBL] [Abstract][Full Text] [Related]
10. Clinical and histopathological features of progressive-type familial amyloidotic polyneuropathy with TTR Lys54.
Nagasaka T; Togashi S; Watanabe H; Iida H; Nagasaka K; Nakamura Y; Miwa M; Kobayashi F; Shindo K; Shiozawa Z
J Neurol Sci; 2009 Jan; 276(1-2):88-94. PubMed ID: 18930252
[TBL] [Abstract][Full Text] [Related]
11. Transthyretin amyloidosis in patients with undifferentiated heart failure.
Chang IC; Scott CG; Dispenzieri A; AbouEzzeddine O; Lin G; Grogan M
Amyloid; 2019; 26(sup1):33-34. PubMed ID: 31343280
[No Abstract] [Full Text] [Related]
12. Diagnosis of sporadic transthyretin Val30Met familial amyloid polyneuropathy: a practical analysis.
Koike H; Hashimoto R; Tomita M; Kawagashira Y; Iijima M; Tanaka F; Sobue G
Amyloid; 2011 Jun; 18(2):53-62. PubMed ID: 21463231
[TBL] [Abstract][Full Text] [Related]
13. Case report of a young patient with transthyretin amyloidosis associated with Gly67Ala mutation.
Salihoglu A; Yildirim S; Ar MC; Hancer VS; Bozcan S; Yilmaz U; Serin N; Tuzuner N; Celik AF
Amyloid; 2019; 26(sup1):75-76. PubMed ID: 31343303
[No Abstract] [Full Text] [Related]
14. Non-Val30Met mutation, septal hypertrophy, and cardiac denervation in patients with mutant transthyretin amyloidosis.
Hirakawa K; Takashio S; Marume K; Yamamoto M; Hanatani S; Yamamoto E; Sakamoto K; Izumiya Y; Kaikita K; Oda S; Utsunomiya D; Shiraishi S; Ueda M; Yamashita T; Yamashita Y; Ando Y; Tsujita K
ESC Heart Fail; 2019 Feb; 6(1):122-130. PubMed ID: 30284755
[TBL] [Abstract][Full Text] [Related]
15. Unexplained cardiac failure leading to the identification of a Belgian family affected by hereditary amyloidosis.
De Pasqual A; Biessaux Y; Blettard N; Crémers S; Caers J
Acta Clin Belg; 2013; 68(4):303-5. PubMed ID: 24455802
[TBL] [Abstract][Full Text] [Related]
16. Cardiac findings and events observed in an open-label clinical trial of tafamidis in patients with non-Val30Met and non-Val122Ile hereditary transthyretin amyloidosis.
Damy T; Judge DP; Kristen AV; Berthet K; Li H; Aarts J
J Cardiovasc Transl Res; 2015 Mar; 8(2):117-27. PubMed ID: 25743445
[TBL] [Abstract][Full Text] [Related]
17. The morphology of amyloid fibrils and their impact on tissue damage in hereditary transthyretin amyloidosis: An ultrastructural study.
Koike H; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Sakurai T; Shimohata T; Katsuno M; Sobue G
J Neurol Sci; 2018 Nov; 394():99-106. PubMed ID: 30243104
[TBL] [Abstract][Full Text] [Related]
18. Common clinicopathological features in late-onset hereditary transthyretin amyloidosis (Ala97Gly, Val94Gly and Val30Met).
Koike H; Nakamura T; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Yasuda T; Mukai E; Date Y; Shiomi K; Nakazato M; Katsuno M; Sobue G
Amyloid; 2019; 26(sup1):24-25. PubMed ID: 31343348
[No Abstract] [Full Text] [Related]
19. Cardiac Involvement in a Patient Cohort With Val30Met Mutation Transthyretin Amyloidosis.
Ripoll-Vera T; Buades J; Cisneros E; Gómez Y; Núñez J; Raya M
Rev Esp Cardiol (Engl Ed); 2019 Jan; 72(1):92-94. PubMed ID: 29223374
[No Abstract] [Full Text] [Related]
20. Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report.
Yamamoto H; Hashimoto T; Kawamura S; Hiroe M; Yamashita T; Ando Y; Yokochi T
J Med Case Rep; 2018 Dec; 12(1):370. PubMed ID: 30553273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
